NANOGP8 and cancer: We finally demonstrate that most long-term cultured somatic cancer cells seem to express very low levels of or biochemically divergent endogenous NanogP8 such that it cannot be readily immunoprecipitated down by the 8 commercial anti-NanogP8 antibodies.